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Cryopreservation of Human 




Cryopreservation is a worldwide technique that makes it possible to preserve 
different living cells and tissues, including male and female gametes and embryos, 
in a structurally intact state using low temperature over time. Since the starting 
point of the cryopreservation era in 1776, until today, this was one of the most 
important steps in assisted reproductive techniques. Conventional slow freezing of 
spermatozoa is commonly used for cryopreservation of both ejaculated and surgi-
cally retrieved spermatozoa. The technique of the slow freezing is principally based 
on dehydration of cells which is performed through slow cooling combined with low 
concentrations of a cryoprotectant agent for achieving a balance. Besides of slow 
freezing, for more than a decade, many reports suggest the sperm vitrification tech-
nique as an alternative to slow freezing. Contrary to the slow freezing method, with 
vitrification, the effects of the cryoprotectants in spermatozoa are eliminated since 
this method is cryoprotectant-free. All of these interesting and promising protocols 
of vitrification, however, have not been implemented in the lab routine yet, and 
slow freezing remains the standard cryopreservation method in most laboratories 
worldwide.
Keywords: cryopreservation, vitrification, permeable and non-permeable 
cryoprotectants, human spermatozoa
1. Introduction
Cryopreservation, derived from the Greek word κρύος (krýos, “icy cold, 
chill, frost”), is a worldwide technique that makes it possible to preserve differ-
ent living cells and tissues, including male and female gametes and embryos, 
in a structurally intact state using low temperature over time. It has become 
an indispensable part of most human-assisted reproductive technology (ART) 
programs around the world. Since the starting point of the cryopreservation era 
in 1776, Spallanzani [1] used snow to freeze spermatozoa and assess their motility 
after thawing. One century later, Mantegazza (reported by Curry [2]) observed 
that human sperm survived frozen at −17°C for more than 4 days. Since the late 
1930–1940s [3, 4], scientists have effectively cryopreserved spermatozoa of 
several mammalian species, especially bovine and human. In 1947, glycerol was 
rediscovered as a cryoprotective agent allowing to freeze viable spermatozoa for 
longer periods. Bernstein and Petropavlovski [3] demonstrated the positive effect 
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of 1 mol/l glycerol on spermatozoa frozen to −21°C in the rabbit, guinea pig, bull, 
ram, stallion, and boar. After that in the late 1940s, the results of experiments 
based on the use of glycerol by Polge et al. [4] in the United Kingdom (1949) 
were published. The first piglet born from frozen–thawed porcine sperm in 1957 
showed that the fertilizing potential could also be preserved and no major harm 
to the genetic apparatus was done [5].
Some cryopreservation methods developed in the 1950s are in use till now. 
However, the real success of cryopreservation was achieved in the 1970s with the 
introduction of dry ice and liquid nitrogen vapor. Following the report published 
in 1964, for the first time, human spermatozoa were successfully cryopreserved 
[6]. Definitely, this was one of the most important steps in assisted reproductive 
techniques, since the preservation of male sample in some conditions is the only 
opportunity to preserve fertility for some couples. Besides that, sperm cryopreser-
vation is also considered as a rescue option for cases prior to radiotherapy and/or 
chemotherapy [7] in cancer patients, prior to any other medical procedure that may 
potentially lead to testicular failure or ejaculatory dysfunction as vasectomy [8], 
as well as in cases of traveling husbands serving in the military or absent partners. 
Even in pediatric oncologic cases, in which testicular tissue can be preserved, the 
cryopreservation of immature testicular tissue for later fertilization purposes seems 
also advisable. Generally, sperm cryopreservation when correctly performed allows 
long-term storage and usage when needed, which is one of the most essential parts 
in assisted reproductive techniques.
Complete cryopreservation as a technique consists three steps: the first one is a 
collection of the sample, the second is the freezing procedure, and the third is the 
storage part in liquid nitrogen [9]. For the male gamete cryopreservation, collecting 
a sample can be divided into collecting ejaculated spermatozoa, collecting epididy-
mal spermatozoa, and collecting testicular spermatozoa. The first one, collecting 
ejaculated spermatozoa, should be always the first option when the patient is 
capable to provide a sample with adequate sperm viability; since intracytoplasmic 
sperm injection (ICSI) allows that sperm is directly injected inside of the oocyte, 
minimum requirement for semen parameters do not exist. On the other hand, the 
complete absence of sperm in the ejaculate following 2–3 days of abstinence on at 
least two occasions is the standard used to confirm the diagnosis of azoospermia; in 
this case, epididymal and testicular collecting of spermatozoa are usual procedures 
[9, 10]. Percutaneous epididymal sperm aspiration (PESA) does not require a surgi-
cal incision. A small needle is going directly into the head of the epididymis through 
the scrotal skin, and fluid is aspirated and examined for the presence of motile 
sperm. On the other side, microsurgical epididymal sperm aspiration (MESA) 
involves dissection of the epididymis under the operating microscope and incision 
of a single tubule. Fluid spills from the epididymal tubule and then is aspirated. 
Epididymal spermatozoa are mature and progressively motile, and epididymal 
aspirates are much cleaner and devoid of the cellular debris that is seen in testicular 
sperm preparations [10]. For the testicular sperm extraction (TESE) procedures, 
different techniques have been developed and compared. The microsurgical TESE 
seems to have the highest sperm retrieval rate and may limit damage to the testicu-
lar tissue. Spermatozoa can be retrieved from tubules that are dilated, and this can 
be visualized with an operating microscope. This technique needs microsurgical 
skills and general anesthesia is usually required. An open biopsy also allows the 
excision of a larger tissue mass, allowing access to a greater number of sperm avail-
able for freezing [10, 11]. Besides these freezing steps, the thawing procedure is an 
equivalently important step. Spermatozoa must be allowed to retrieve its normal 
biological activities. Generally speaking, at the present time, all the cryopreserva-
tion protocols use a thawing temperature of 37°C for 10 or 15 min [12].
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2. The conventional “slow freezing” method
Conventional slow freezing of spermatozoa is commonly used for cryopreser-
vation of both ejaculated and surgically retrieved spermatozoa. The technique of 
slow freezing is principally based on dehydration of cells [13] which is performed 
through slow cooling combined with low concentrations of a cryoprotectant agent 
for achieving a balance. Slow freezing of spermatozoa is commonly performed by 
stepwise manual or continuous programmed freezing of vials or straws, containing 
a mixture of cryoprotectants and spermatozoa, to subzero temperatures [14]. The 
manual method is performed by simultaneously decreasing the temperature of 
the semen while adding a cryoprotectant in a stepwise manner and after immers-
ing the samples into liquid nitrogen [15]. Mahadevan et al. [16] reported that 
the optimal initial cooling rate of the specimen from room temperature to 5°C is 
0.5–1°C/min. The sample is then frozen from 5°C to −80°C at a rate of 1–10°C/min 
and then submerged into liquid nitrogen at −196°C. Despite the fact many research 
presented successful sperm freezing with manual techniques, the reproducibility 
of this procedure pointed out some problems. For this reason, programmable 
freezers have been investigated [17]. These devices generally use a plate to hold the 
straws; these are cooled by liquid nitrogen held in a storage tank under the plate. 
Liquid nitrogen is poured into the tank, and the machine, once programmed, uses 
the software data logging to obtain cooling from 20°C to −80°C at a rate of 1.5°C/min 
and then at 6°C/min; at completion of the freezing, the straws are removed and 
stored in liquid nitrogen at −196°C. This takes about 40 min [17]. Software is 
simple to use and do not require continuous operator intervention and, besides 
that, have been used to increase the reproducibility of the freezing operations.
However, many research confirmed that the cryopreserved/thawed spermatozoa 
lose about 50–40% of their pre-freezing motility value, with considerable fluctua-
tion among samples [18]. Although, after freezing, the regression of the motility is 
one of the first affected parameters, the mechanism of sperm impairment and its 
mechanical, physical, and/or chemical etiology is still the point of discussion. The 
ice equilibrium in conventional slow freezing is one of the main causes of mechani-
cal cell injury, which result in the formation of intra- or extracellular ice crystal, 
along with the osmotic damage [19].
The cell further downgrades as well through consequent thawing and rewarm-
ing that affect their viability by possible excessive osmotic swelling. Chemical and 
physical damage are also caused affecting the sperm cell membranes as a result of 
expanded lipid peroxidation, due to the production of reactive oxygen species [20] 
which also lead to loss of sperm motility [21]. In order to prevent all the previously 
reported damages, during the time, different cryoprotectants were developed. 
Cryoprotectants are low-molecular-weight and highly permeable chemicals used 
to protect spermatozoa from freeze damage by ice crystallization. There are four 
main well-known cryoprotectants: glycerol, ethylene glycol, dimethyl sulfoxide, 
and 1,2-propanediol. Cryoprotectants decrease the freezing point of a sample, 
reduce the amount of salts and solutes present in the liquid phase of the sample, and 
decrease ice formation within the spermatozoa [22]. Usually, the cryoprotectants 
are added in an equal volume of semen in a dropwise manner, gently mixed at room 
temperature, and then placed at 37°C for 10–15 min to allow for proper equilibra-
tion between the cells and the medium [23]. Besides the permeable cryoprotectants, 
there are non-permeable agents, such as raffinose, sucrose, egg yolk citrate, albu-
min, polyethylene glycol, and polyvinylpyrrolidone, which are common additives 
that cannot pass through the plasma membrane but have antioxidant effects and are 
used to improve post-thaw sperm functional parameters such as post-thaw motility, 
viability, and reducing DNA damage [12]. Presently, slow freezing techniques have 
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been widely used in sperm cryopreservation with acceptable results for sperm vital-
ity and motility after thawing [24]. However, for more than a decade, many reports 
suggest sperm vitrification technique as an alternative to slow freezing [25].
3. Vitrification as an alternative: new technique
In the past, the first successful vitrification of frog spermatozoa was done by 
Luyet and Hodapp [26] and fowl spermatozoa 4 years later by Shaffner [27]. In the 
early 1980s, Rall and Fahy [28] managed to successfully vitrify embryos using high 
concentrations of permeable cryoprotective agents and a relatively low speed of 
cooling and warming, and since then, the main approach to vitrifying spermatozoa 
has been considered the same as the methods used for other types of mammalian 
cells [29]. Vitrification as a method is based on the ultrarapid increase and decrease 
of temperatures with or without the use of non-permeable cryoprotectants. During 
the procedure, water is cooled to a glassy state through extreme increasing of 
viscosity without intracellular ice crystallization making this procedure less labor-
intensive, faster, and presumably safer than traditional slow freezing protocols [30].
Contrary to the slow freezing method, the effects of the cryoprotectants in 
spermatozoa are eliminated since this method is cryoprotectant-free. Using this 
method, the sperm suspension is plunged directly into liquid nitrogen, and the 
sperm cells are cooled in an ultrarapid manner, known as kinetic vitrification [25]. 
What is more, cryoprotectant-free technique avoids the use of the classic toxic cryo-
protective agents (CPA) that may have lethal effects of osmotic shock and prevent 
lethal intracellular ice formation and the harmful effects of high salt concentra-
tions during freezing and thawing [25]. The first described cryoprotectant-free 
vitrification by Nawroth et al. [31] suggested that spermatozoa were located onto 
copper loops or into standard 0.25 ml insemination straws and plunged directly 
into liquid nitrogen. During the years of improving technique, different devices 
have been tested [30, 32, 33]. Isachenko et al. [34] compared the vapor phase and 
liquid phase for sperm cryopreservation, using the cryoloop, droplet, and open 
straw methods. Cryoloops with a film of spermatozoa suspension were cooled for 
3 min in liquid nitrogen vapor at −160°C and then placed into pre-cooled cryovials 
(CryoTubesTM, 4.5 ml volume, 92 mm length; Nunc GmbH & Co. KG, Wiesbaden, 
Germany) and were stored in liquid nitrogen until the time of warming. The 
second developed method at that time was vitrification in liquid nitrogen vapor 
using droplets where sperm suspension was located onto aluminum foil previously 
cooled in liquid nitrogen vapor to −160°C. During cooling, the droplet of sperm 
suspension adopted a spherical form, which was placed into pre-cooled cryovials 
and stored in liquid nitrogen. With open straw method, sperm suspension was 
drawn inside the end of open-pulled straws (0.25 ml) (Medical Technology GmbH, 
Altdorf, Germany) by capillary action [32]. Straws were placed inside other sterile 
90 mm straws which were prepared from the standard 0.5 ml insemination straws 
(Medical Technology GmbH, Altdorf, Germany) and then hermetically closed 
using a handheld sealer and then plunged into liquid nitrogen. During this pro-
cedure, it was described that there was no contact between the wall of the 90 mm 
straw and the suspension of spermatozoa inside the open-pulled straws, due to the 
presence of a meniscus in the suspension [34]. At the end, the results report that 
CPA-free cryopreservation of spermatozoa could occur in a wide range of cooling 
rates, but the major disadvantage of cryoprotectant-free vitrification was that only 
small volumes of spermatozoa (≤40 μl) could be vitrified in these systems [32].
What is more, in the aim to improve the cryoprotectant-free vitrification, Schulz 
et al. [35] added some carbohydrate supplements (glucose, sucrose, and trehalose) 
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to the sperm suspension and obtained that sucrose has increased spermatozoa 
motility and viability after thawing. Later on, Isachenko et al. [36] investigates the 
ability of sucrose to protect sperm motility, viability, mitochondrial membrane 
potential integrity, spontaneous capacitation, and acrosome reaction. Spermatozoa 
were cryoprotectant-free vitrified using three different media: human tubal fluid 
medium (control), human tubal fluid medium with 1% human serum albumin, and 
fluid medium with 1% human serum albumin and 0.25 M sucrose [36].
Obtained results in this research [36] indicate that the number of progressively 
motile spermatozoa was significantly higher in the sucrose-supplemented medium 
group (57%) than with controls (19%). The combination of fluid medium with 1% 
human serum albumin and sucrose (65%) has a stronger cryoprotective effect on 
the integrity of mitochondrial membrane potential than with human tubal fluid 
medium with 1% human serum albumin alone (33%). It was concluded that cryo-
protectant-free vitrification of human spermatozoa with non-permeable cryopro-
tectants such as human serum albumin and sucrose can effectively cryopreserve the 
cells without significant loss of important physiological parameters. On the other 
hand, Chen et al. [37] reported that normozoospermic patient samples vitrified 
by the cryoprotectant-free method with or without the addition of sucrose did not 
show a significant difference in the sperm recovery rate and motility rate.
During the years, many researchers got their attention into the vitrification 
of oocytes, embryos, larger cells, and even tissues [38–40]. It was established, at 
that time, that vitrification for oocyte and embryo could not be achieved without 
combinations of high concentrations of both permeable and non-permeable cryo-
protectants in order to reach stable vitrification and allow using a relatively low rate 
of cooling and warming. Mainly dimethyl sulfoxide, propanediol, or ethylene glycol 
were used for ooctyte and embryo vitrification [41–43]. However, these methods 
also have their limitations, and especially human spermatozoa are intolerant to the 
high concentrations of cryoprotectants conventionally used in vitrification [44, 45]. 
Suggested reasons for successful vitrification in the absence of cryoprotectants for 
spermatozoa are the size of the cells and their relative concentration of soluble mac-
romolecules. The shape and size of the sperm head could define the cryo-sensitivity 
of the cell. Comparative studies [46] have shown a negative correlation between 
the size of the sperm head and cryo-stability. Oocyte and spermatozoa naturally 
contain high concentrations of proteins, which help in vitrification. Thus, a higher 
cryoprotectant concentration is needed for extracellular vitrification than for intra-
cellular vitrification [25]. It can be assumed that the amount of osmotically inactive 
water is also higher in spermatozoa and is combined with several macromolecular 
structures such as DNA, histones, etc. [47]. Extensive classification of intracellular 
compounds may also contribute to the successful survival of spermatozoa [48].
In spite of this, vitrification of spermatozoa is still a rather unexplored method-
ology, with limited studies showing its efficacy in male gametes [24, 25, 30–32]. In 
the last two decades, different sperm vitrification protocols have been published, 
most of them developed by Isachenko [30–32, 34, 36] where not only different 
combinations of cryoprotection but also different devices have been tested as well. 
These interesting and promising protocols, however, have not been implemented in 
the IVF lab routine yet, and slow freezing remains the standard cryopreservation 
method in most laboratories worldwide [49].
4. Our experience
Since there is no optimal accepted algorithm for the vitrification procedure and 
no evidence has been established regarding the possibility of achieving successful 
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human spermatozoa vitrification without cryoprotectant, the differences between 
vitrification of human sperm with and without two non-permeable cryoprotectants 
(NPC), sucrose (SUC), and trehalose (TRE) were investigated. For that, five human 
semen samples diagnosed as normal (normozoospermia) were obtained and analyzed. 
All samples were prepared through 80% one-step density gradient and then were 
diluted to a defined sperm concentration of 40 × 106 sperms per ml. following the 
guidelines of the World Health Organization criteria [13]. Motility and vitality of the 
sperm were recorded in each sample. Each sample was then divided into three parts. 
Each part of the samples underwent vitrification using three different methods: (i) 
150 μl cryostraw filled with the sample was directly plunged into liquid nitrogen, (ii) 
small drops of the samples were dripped into liquid nitrogen, and (iii) microcapil-
laries were plunged directly into liquid nitrogen. Each part was vitrified differently 
using sucrose and trehalose or without a cryoprotectant. Sucrose and trehalose were 
diluted in media, 500 mM, after merging it with the sperm solution concentrations 
till they have reached 250 mM of concentration with 20 × 106 sperms per ml. After 
a minimum of 24 hours of cryopreservation, samples were thawed in warm water at 
37°C for 20 seconds. Then, the samples were washed in 1 ml media (SpermActive®; 
Gynemed) and incubated at 37°C. Motility and vitality were directly assessed, 30 
and 120 min after thawing. It was found that sperms’ overall survival rates ranged 
from 1.2 to 37.5%. Mean survival rates for each method were as follows: method 
(i), 15.5 ± 5.3% for sucrose, 16.6 ± 5.2% for trehalose, and 19.8 ± 7.8% without 
cryoprotectant; method (ii), 47.8 ± 16.6% for sucrose, 53.8 ± 13.4% for trehalose, 
and 40.4 ± 7.5 without cryoprotectant; and method (iii), 10.3 ± 2.9% for sucrose, 8.2 
± 3.9% for trehalose, and 8.2 ± 3.3% without cryoprotectant (Table 1). Statistical 
analyses revealed significant differences only between method (ii) and method (iii) 
(Table 2), with a tendency for better survival rates in method (ii) under all three 
conditions, especially with trehalose (mean survival rate of 53.8 ± 13.4%; Table 1). 
However, these differences are not representative because of the low survival and 
motility rate after thawing for method (iii), which might be affected by the heat 
sealing process (sealing small volume of the sample). No significant differences were 
observed regarding the addition of sucrose and trehalose or vitrification without a 
cryoprotectant in terms of overall survival rates (suc. vs. no cryoprotectant n = 5, 
p > 0.4; tre. vs. no cryoprotectant n = 5, p > 0.3; Table 2). Similarly, no significant 
differences were assessed between the use of sucrose and trehalose (n = 5, p > 0.7). 
Mean motility recovery, measured after 120 min of thawing, was 13.7 ± 5.9% for 
sucrose, 12.8 ± 4.2% for trehalose, and 10.1 ± 4.3% without cryoprotectant, and 
Table 1. 
Mean survival rates for all three methods and conditions.
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between these three groups, there was not a significant difference. However, 
interestingly, a tendency of improved motility was observed during post-thawing 
incubation specifically in addition of cryoprotectants (Figure 1). Therefore, the 
choice of the vitrification method and conditions seems to influence survival rates, 
motility, and vitality of the sperm, but the significant difference in sperm recovery 
after vitrification with non-permeable cryoprotectants was not found; the reason 
Figure 1. 
Recovery of motility by post-thawing incubation.
Table 2. 
Comparison of the different methods.
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that influenced the obtained result might be the small sample size. On the other 
hand, the improvement of the methodology of sperm vitrification could yield in 
positive additional effects of non-permeable cryoprotectants. Under these condi-
tions, obtained data might be encouraging for further studies, to extend on a greater 
number of normal sperm samples as well as to those patients with reduced semen 
quality and fertility problems. Moreover, the increase in post-thaw sperm motility is 
an important aspect in the use of all assisted reproduction techniques and should be 
also confirmed by further studies.
5. Conclusion
Spermatozoa cryopreservation for males is the standard fertility preservation 
care in patients undertaking gonadotoxic treatments, such as chemotherapy/
radiotherapy. The conventional cryopreservation, the slow freezing technique, is 
standardized and commonly used. However, functional sperm parameters includ-
ing motility after the thawing are still challenging. New methods that preserve 
spermatozoa are promising, even though they still need validation before being 
routinely used in an assisted reproduction program, including the essential use of 
new cryoprotectants and new antioxidants to improve sperm quality after thawing. 
Moreover, spermatozoa lyophilization is another method that is still under investi-
gation. However, as the spermatozoa are immotile, lyophilized sperm can only be 
used in ICSI. Hence, future research needs not only to investigate the optimization 
and safety of methods but also for the health of the offspring.
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